Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 5/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | CTSV | O60911 | 2/20 | 0.32 |
| ▸ | CTSL | P07711 | 2/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25429720 | 0.84 | HSD17B10 (0.55) | HSD17B10TRPV1ALDH1A1BRD4TNKS2 | |
| SCHEMBL25430647 | 0.80 | HSD17B10 (0.55) | HSD17B10TRPV1ALDH1A1KDM4EMAPT | |
| SCHEMBL25955024 | 0.71 | TRPV1 (0.49) | TRPV1KDM4EBRD4TNKS2 | |
| SCHEMBL25429394 | 0.70 | HSD17B10 (0.52) | HSD17B10TRPV1PDE10A | |
| SCHEMBL25431622 | 0.70 | HSD17B10 (0.51) | HSD17B10TRPV1ALDH1A1MAPT | |
| SCHEMBL25427626 | 0.70 | HSD17B10 (0.51) | HSD17B10TRPV1ALDH1A1 | |
| SCHEMBL25432084 | 0.67 | HSD17B10 (0.46) | HSD17B10BRD4 | |
| SCHEMBL25430366 | 0.66 | TTBK1 (0.42) | HSD17B10BRD4 | |
| SCHEMBL25429117 | 0.65 | HSD17B10 (0.55) | HSD17B10TRPV1ALDH1A1MAPT | |
| SCHEMBL25429629 | 0.65 | TRPV1 (0.46) | TRPV1BRD4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023146511-A1 | COMPOUNDS AND METHODS OF USE THEREOF | VIVACE THERAPEUTICS, INC. (US) | 2023-08-03 | — | — | WO | disclosed |